EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PET imaging of PARP expression using 68Ga-labelled inhibitors

Xiangwei Wang, Wei Liu, Ke Li, Kaiwen Chen, Simin He, Jianping Zhang, Bingxin Gu, Xiaoping Xu, Shaoli Song

European Journal of Nuclear Medicine and Molecular Imaging · 2023-07 · 50 (9) · 2606-2620

DOI: 10.1007/s00259-023-06249-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 05.05.2023. Verfasst von Xiangwei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Imaging the PARP expression using 18 F probes has been approved in clinical trials. Nevertheless, hepatobiliary clearance of both 18 F probes hindered their application in monitoring abdominal lesions. Our novel 68 Ga-labelled probes aim for fewer abdominal signals while ensuring PARP targeting by optimizing the pharmacokinetic properties of radioactive probes.

Methods

Three radioactive probes targeted PARP were designed, synthesized, and evaluated based on the PARP inhibitor Olaparib. These 68 Ga-labelled radiotracers were assessed in vitro and in vivo.

Results

Precursors that did not lose binding affinity for PARP were designed, synthesized, and then labelled with 68 Ga in high radiochemical purity (> 97%). The 68 Ga-labelled radiotracers were stable. Due to the increased expression of PARP-1 in SK-OV-3 cells, the uptake of the three radiotracers by SK-OV-3 cells was significantly greater than that by A549 cells. PET/CT imaging of the SK-OV-3 models indicated that the tumor uptake of 68 Ga-DOTA-Olaparib (0.5 h: 2.83 ± 0.55%ID/g; 1 h: 2.37 ± 0.64%ID/g) was significantly higher than that of the other 68 Ga-labelled radiotracers. There was a significant difference in the T/M (tumor-to-muscle) ratios between the unblocked and blocked groups as calculated from the PET/CT images (4.07 ± 1.01 vs. 1.79 ± 0.45, P = 0.0238 < 0.05). Tumor autoradiography revealed high accumulation in tumor tissues, further confirming the above data. PARP-1 expression in the tumor was confirmed by immunochemistry.

Conclusion

As the first 68 Ga-labelled PARP inhibitor, 68 Ga-DOTA-Olaparib displayed high stability and quick PARP imaging in a tumor model. This compound is thus a promising imaging agent that can be used in a personalized PARP inhibitor treatment regimen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyPoly(ADP-ribose) Polymerase InhibitorsHumansGallium RadioisotopesCell Line, TumorPositron-Emission Tomography

Stichwörter der Autor:innen

68GaOlaparibPARPPET/CT imagingTumors

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsGallium Radioisotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, China.
  • College of Chemistry and Materials Science, Shanghai Normal University, Shanghai, China.
  • Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. xxp0012@ustc.edu.
  • Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, China. xxp0012@ustc.edu.
  • Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. shaoli-song@163.com.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Liu, W., Li, K., Chen, K., He, S., Zhang, J., Gu, B., Xu, X., & Song, S. (2023). PET imaging of PARP expression using 68Ga-labelled inhibitors. European Journal of Nuclear Medicine and Molecular Imaging, 50(9), 2606-2620. https://doi.org/10.1007/s00259-023-06249-6

Vancouver

Wang X, Liu W, Li K, Chen K, He S, Zhang J, et al. PET imaging of PARP expression using 68Ga-labelled inhibitors. European Journal of Nuclear Medicine and Molecular Imaging. 2023;50(9):2606-2620. doi:10.1007/s00259-023-06249-6

BibTeX
@article{Wang2023,
  author = {Wang, Xiangwei and Liu, Wei and Li, Ke and Chen, Kaiwen and He, Simin and Zhang, Jianping and Gu, Bingxin and Xu, Xiaoping and Song, Shaoli},
  title = {PET imaging of PARP expression using 68Ga-labelled inhibitors},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  volume = {50},
  number = {9},
  pages = {2606--2620},
  doi = {10.1007/s00259-023-06249-6}
}
Kostenlos starten →